Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 3,559

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Open access
Tang, Ning, Bai, Huan, Chen, Xing, Gong, Jiale, Li, Dengju, Sun, Ziyong·2020·Journal of Thrombosis and Haemostasis

Abstract

A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy remains to be validated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jth.14817

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 20

  1. Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemost, 10.1111/jth.14768 · DOI · Paper page
  2. 2020, Comprehensive treatment and management of coronavirus disease 2019: expert consensus statement from Shanghai (in Chinese), Chin J Infect Dis, 38
  3. Iba, 2019, Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation, J Thromb Haemost, 17, 1989, 10.1111/jth.14578 · DOI · Paper page
  4. Iba, 2017, New criteria for sepsis‐induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey, BMJ Open, 7, 10.1136/bmjopen-2017-017046 · DOI · Paper page
  5. National Health Commission of China. The diagnosis and treatment plan for the novel coronavirus disease (the seventh edition). 2020.
  6. Venclauskas, 2018, European guidelines on perioperative venous thromboembolism prophylaxis: day surgery and fast‐track surgery, Eur J Anaesthesiol, 35, 134, 10.1097/EJA.0000000000000706 · doi:10.1097/eja.0000000000000706
  7. Levi, 2017, Coagulation and sepsis, Thromb Res, 149, 38, 10.1016/j.thromres.2016.11.007 · DOI · Paper page
  8. Schmitt, 2019, Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study, Ann Intensive Care, 9, 19, 10.1186/s13613-019-0499-6 · DOI · Paper page
  9. Gupta, 2019, The stimulation of thrombosis by hypoxia, Thromb Res, 181, 77, 10.1016/j.thromres.2019.07.013 · DOI · Paper page
  10. Poterucha, 2017, More than an anticoagulant: do heparins have direct anti‐inflammatory effects?, Thromb Haemost, 117, 437, 10.1160/TH16-08-0620 · DOI · Paper page
  11. Stein, 2004, Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census, Am J Med, 116, 435, 10.1016/j.amjmed.2003.11.020 · DOI · Paper page
  12. Zakai, 2011, Racial differences in venous thromboembolism, J Thromb Haemost, 9, 1877, 10.1111/j.1538-7836.2011.04443.x · DOI
  13. Aikawa, 2011, Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial, Shock, 35, 349, 10.1097/SHK.0b013e318204c019 · doi:10.1097/shk.0b013e318204c019
  14. Liu, 2014, Low‐dose heparin as treatment for early disseminated intravascular coagulation during sepsis: a prospective clinical study, Exp Ther Med, 7, 604, 10.3892/etm.2013.1466 · doi:10.3892/etm.2013.1466
  15. Nishida, 2018, The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J‐SSCG 2016), Acute Med Surg, 5, 3, 10.1002/ams2.322 · DOI
  16. Umemura, 2016, Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta‐analysis of randomized controlled trials, J Thromb Haemost, 14, 518, 10.1111/jth.13230 · DOI · Paper page
  17. Iba, 2014, Anticoagulant therapy for sepsis‐associated disseminated intravascular coagulation: the view from Japan, J Thromb Haemost, 12, 1010, 10.1111/jth.12596 · DOI
  18. Menter, 2017, Platelet "first responders" in wound response, cancer, and metastasis, Cancer Metastasis Rev, 36, 199, 10.1007/s10555-017-9682-0 · DOI · Paper page
  19. Sun, 2009, Reduced thrombin generation increases host susceptibility to group A streptococcal infection, Blood, 113, 1358, 10.1182/blood-2008-07-170506 · DOI
  20. Dong, 2020, Discovering drugs to treat coronavirus disease 2019 (COVID‐19), Drug Discov Ther, 14, 58, 10.5582/ddt.2020.01012 · DOI · Paper page

Cited by

See all 3,559

Metadata

Authors
Tang, N., Bai, H., Chen, X., Gong, J., Li, D., & Sun, Z.
Venue
Journal of Thrombosis and Haemostasis
Publisher
Elsevier BV
Published
2020-05
Volume
18
Issue
5
Pages
1094-1099
ISSN
1538-7836 (ISSN-L)
OpenAlex
W3013486442
Cited by
3,559
References
4
FWCI
100.92
Type
journal article
Language
en
Open access
bronze
Licence
Funders
National Mega Project on Major Infectious Disease Prevention of China (2017ZX10103005-007)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. https://app.cochat.ai/papers/10.1111/jth.14817
The paper
Tang, N., Bai, H., Chen, X., Gong, J., Li, D., & Sun, Z. (2020). Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. Journal of Thrombosis and Haemostasis. https://doi.org/10.1111/jth.14817

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.